{"url_path":"/sec/bhvn/8-k/2026-07-09/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-09","source_url":"https://www.sec.gov/Archives/edgar/data/1935979/0001935979-26-000053-index.html","accession_number":"0001935979-26-000053","cik":"0001935979","ticker":"BHVN","issuer_name":"Biohaven Ltd.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1935979/0001935979-26-000053-index.html","primary_entity_key":"0001935979","primary_entity_name":"Biohaven Ltd."},"word_count":82,"has_tables":true,"body_markdown":"Item 9.01    Financial Statements and Exhibits.\n\n(d) Exhibits\n\nExhibit NumberExhibit Description\n\n99.1\n[Press Release, Dated J](exhibit991biohavenannounce.htm)[uly](exhibit991biohavenannounce.htm)[9](exhibit991biohavenannounce.htm)[, 2026,](exhibit991biohavenannounce.htm)[“Biohaven Announces Scientific Leadership Transitions”](exhibit991biohavenannounce.htm)\n\n104The cover page of this Current Report on Form 8-K formatted as Inline XBRL.\n\n2\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nDate: July 9, 2026\n\nBiohaven Ltd.\n\nBy:/s/ Matthew Buten\n\nMatthew Buten\n\nChief Financial Officer\n\n3"}